EU regulators also backed Trelegy
AstraZeneca has signed a five-year strategic research collaboration with Ethris, an mRNA-based therapeutics company specialising in pulmonary disease.
Drugs improve on existing medicines from Boehringer and Roche.
UK biotech hopes RPL554 could be a disease modifying drug.
FDA accepts Sandoz filing for Advair Diskus generic.
Italian firm takes on mighty GSK
Chiesi takes on Seretide and other lung drugs with Trimbow.